(NYSE: STE) Steris's forecast annual revenue growth rate of 5.99% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.62%.
Steris's revenue in 2025 is $5,702,501,000.On average, 11 Wall Street analysts forecast STE's revenue for 2026 to be $587,311,701,856, with the lowest STE revenue forecast at $567,486,006,038, and the highest STE revenue forecast at $611,848,454,106. On average, 11 Wall Street analysts forecast STE's revenue for 2027 to be $623,920,536,213, with the lowest STE revenue forecast at $590,943,141,189, and the highest STE revenue forecast at $656,897,931,237.
In 2028, STE is forecast to generate $668,282,984,281 in revenue, with the lowest revenue forecast at $643,648,085,022 and the highest revenue forecast at $707,443,640,872.